Status epilepticus (SE) treatment strategies vary substantially from one institution to another
due to the lack of data to support one treatment over another. To provide guidance for the …

Benzodiazepines (BZDs) remain important agents in the management of epilepsy. They are
drugs of first choice for status epilepticus and seizures associated with post‐anoxic insult …

Background: New continuous infusion antiepileptic drugs (cIV‐AEDs) offer alternatives to
pentobarbital for the treatment of refractory status epilepticus (RSE). However, no …

A patient in status epilepticus has continuous or rapidly repeating seizures. Although the
danger of this pattern of seizure activity has been recognized since antiquity, our …

Summary As in Clark and Prout's classic work, we identify three phases of generalised
convulsive status epilepticus, which we call impending, established, and subtle. We review …

Purpose: Established tonic–clonic status epilepticus (SE) does not stop in one-third of
patients when treated with an intravenous (IV) benzodiazepine bolus followed by a loading …

Nonconvulsive status epilepticus (NCSE) is characterized by behavioral or cognitive change
from baseline for at least 30 minutes with EEG evidence of seizures. Categorized into …

Background: Although cIV-MDZ has emerged as a popular alternative to barbiturate therapy
for refractory status epilepticus (RSE), experience with its use for this indication is limited …

Purpose: We compared propofol with high‐dose barbiturates in the treatment of refractory
status epilepticus (RSE) and propose a protocol for the administration of propofol in RSE in …

Purpose: To explore outcome differences between propofol and midazolam (MDL) therapy
for refractory status epilepticus (RSE). Methods: Retrospective chart review of consecutive …